Video

What's New in Metastatic Breast Cancer Research

Nancy Lin, MD, of the Susan F. Smith Center for Women's Cancers at the Dana Farber Cancer Institute, discusses the differences between breast cancer subtypes and looks at recent drug approvals and research directions for the future.

Nancy Lin, MD, of the Susan F. Smith Center for Women’s Cancers at the Dana Farber Cancer Institute, discusses the differences between breast cancer subtypes and looks at recent drug approvals and research directions for the future.

Related Videos
Image credit: JJAVA | stock.adobe.com
Related Content
Pharmacist Spotlight: Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES, CTTS
April 17th 2025

Pharmacist Spotlight: Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES, CTTS

PT Staff Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES, CTTS
Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange
April 14th 2025

Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Alexandra Gerlach, Associate Editor
Gut health -- Image credit: sdecoret | stock.adobe.com
April 16th 2025

Essential Immune Cells in Intestine Causes Gut Inflammation, Allergic Responses to Foods When Absent

Gillian McGovern, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Palliative care pharmacist -- Image credit: Meeko Media | stock.adobe.com
April 16th 2025

More Than Just Meds: What a Palliative Care Pharmacist Learned From the Bedside

Trinh Bui, PharmD
Health care professional hands holding a hepatitis liver -- Image credit: mi_viri | stock.adobe.com
April 15th 2025

Study: Hepatic PTPRD Expression Impaired in Etiologies of Chronic Liver Disease Associated With Metabolic Disease

Gillian McGovern, Associate Editor